National Vision - EYE Stock Forecast, Price & News

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Vision in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" EYE shares.
View EYE analyst ratings or view top-rated stocks.

6 equities research analysts have issued 12 month target prices for National Vision's shares. Their EYE share price forecasts range from $24.00 to $45.00. On average, they expect the company's stock price to reach $32.00 in the next year. This suggests a possible upside of 71.9% from the stock's current price.
View analysts price targets for EYE or view top-rated stocks among Wall Street analysts.

National Vision's stock was trading at $38.76 on January 1st, 2023. Since then, EYE shares have decreased by 52.0% and is now trading at $18.62.
View the best growth stocks for 2023 here.

National Vision saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 5,470,000 shares, a decrease of 23.0% from the February 28th total of 7,100,000 shares. Based on an average daily volume of 1,220,000 shares, the short-interest ratio is presently 4.5 days. Approximately 7.0% of the company's stock are sold short.
View National Vision's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023.
View our EYE earnings forecast.

National Vision Holdings, Inc. (NASDAQ:EYE) issued its quarterly earnings data on Wednesday, March, 1st. The company reported ($0.11) EPS for the quarter, hitting the consensus estimate of ($0.11). The business earned $468.93 million during the quarter, compared to analysts' expectations of $471.61 million. National Vision had a trailing twelve-month return on equity of 4.16% and a net margin of 2.10%.

ETFs with the largest weight of National Vision (NASDAQ:EYE) stock in their portfolio include Invesco S&P SmallCap Consumer Discretionary ETF (PSCD), SPDR S&P Retail ETF (XRT), Direxion Daily Retail Bull 3X Shares (RETL), Vanguard S&P Small-Cap 600 Growth ETF (VIOG), Vanguard S&P Small-Cap 600 ETF (VIOO), Vanguard S&P Small-Cap 600 Value ETF (VIOV), Franklin U.S. Small Cap Multifactor Index ETF (FLQS) and iShares S&P Small-Cap 600 Growth ETF (IJT).

National Vision declared that its Board of Directors has authorized a share repurchase program on Monday, November 29th 2021, which allows the company to repurchase $100,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 2.5% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's board of directors believes its shares are undervalued.

National Vision issued an update on its FY 2023 earnings guidance on Wednesday, March, 1st. The company provided EPS guidance of $0.42-$0.60 for the period, compared to the consensus EPS estimate of $0.98. The company issued revenue guidance of $2.08 billion-$2.13 billion, compared to the consensus revenue estimate of $2.14 billion.

243 employees have rated National Vision Chief Executive Officer L. Reade Fahs on Glassdoor.com. L. Reade Fahs has an approval rating of 97% among the company's employees. This puts L. Reade Fahs in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other National Vision investors own include Verizon Communications (VZ), Enterprise Products Partners (EPD), AT&T (T), Carnival Co. & (CCL), Antares Pharma (ATRS), Advanced Micro Devices (AMD), Gilead Sciences (GILD), QUALCOMM (QCOM), Tanger Factory Outlet Centers (SKT) and STMicroelectronics (STM).

(EYE) raised $300 million in an IPO on Thursday, October 26th 2017. The company issued 15,800,000 shares at $18.00-$20.00 per share. BofA Merrill Lynch, Goldman Sachs, Citigroup, KKR, Morgan Stanley, Jefferies, UBS Investment Bank and Wells Fargo Securities acted as the underwriters for the IPO and Guggenheim Securities, Mizuho Securities and Macquarie Capital were co-managers.

National Vision trades on the NASDAQ under the ticker symbol "EYE."

National Vision's stock is owned by many different institutional and retail investors. Top institutional investors include JPMorgan Chase & Co. (9.72%), William Blair Investment Management LLC (8.75%), Alliancebernstein L.P. (5.93%), Clearbridge Investments LLC (5.37%), Macquarie Group Ltd. (3.59%) and Dimensional Fund Advisors LP (2.01%). Insiders that own company stock include Jared Brandman, L Reade Fahs, Melissa Rasmussen, Mfn Partners, Lp, Ravi Acharya and Virginia A Hepner.
View institutional ownership trends.

Shares of EYE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EYE stock can currently be purchased for approximately $18.62.

National Vision (NASDAQ:EYE) has a market capitalization of $1.47 billion and generates $2.01 billion in revenue each year. The company earns $42.12 million in net income (profit) each year or $0.49 on an earnings per share basis.

The company employs 13,975 workers across the globe.

National Vision's mailing address is 2435 COMMERCE AVENUE BLDG. 2200, DULUTH GA, 30096. The official website for the company is www.nationalvision.com. The company can be reached via phone at (770) 822-3600 or via email at investor.relations@nationalvision.com.